Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRAELING, R. R.
Right arrow Articles by KISER, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KRAELING, R. R.
Right arrow Articles by KISER, T. E.
Agricola
Right arrow Articles by KRAELING, R. R.
Right arrow Articles by KISER, T. E.

Biology of Reproduction, Vol 25, 511-518, Copyright © 1981 by Society for the Study of Reproduction

Corpus Luteum Function After Indomethacin Treatment During the Estrous Cycle and Following Hysterectomy in the Gilt

ROBERT R. KRAELING 1, GEORGE B. RAMPACEK 2, , and TERRY E. KISER 2

1 Richard B. Russell Agricultural Research Center, Science and Education Administration, U.S. Department of Agriculture
2 Animal and Dairy Science Department, University of Georgia, Athens, Georgia 30613


Indomethacin (IND), a prostaglandin synthetase inhibitor, was used to determine the relationship between prostaglandin (PG) secretion and corpus luteum (CL) function during the luteal phase of the estrous cycle and after hysterectomy in the gilt. In Experiment 1, gilts that had displayed estrous cycles of 18 to 22 days (onset of estrus = Day 0) were randomly assigned to four treatments (n = 7/group): 1) ethanol vehicle (EtOH) daily from Day 10 through Day 17; 2) IND daily from Day 10 through Day 17;3) IND daily from Day 10 through Day 13 and EtOH daily from Day 14 through Day 17; and 4) EtOH daily from Day 10 through Day 13 and IND daily from Day 14 through Day 17. In Experiment 2, 15 gifts were hysterectomized on Days 6 to l0 of the estrous cycle and were randomly assigned to a control (n = 7) or IND-treated (n = 8) group. Treatment, daily for 4 days, began when all gilts had reached Day 18 or later. The daily dose of 10 mg IND/kg BW was calculated on the average body weight of each treatment group. In Experiment 1, ovarian morphology at necropsy on Day 25, serum progesterone and 13,14-dihydro-15-keto prostaglandin F2agr (PGFM) concentrations throughout the experimental period, and failure to display estrus by Day 25 suggest that IND treatment during the luteal phase of the estrous cycle prolonged CL maintenance in the pig. The progesterone and PGFM assays were validated in our laboratory. In experiment 2, CL morphology and serum progesterone and luteinizing hormone (LH) concentrations indicate that IND treatment failed to affect luteal function by a direct action on the luteal cell or by suppressing pituitary LH secretion.

Submitted on March 23, 1981
Accepted on May 27, 1981






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the Society for the Study of Reproduction.